Use of radiolabelled choline as a pharmacodynamic marker for the signal transduction inhibitor geldanamycin.
about
Drugging the cancer kinome: progress and challenges in developing personalized molecular cancer therapeuticsModulation of melanoma cell phospholipid metabolism in response to heat shock protein 90 inhibition.17-allyamino-17-demethoxygeldanamycin treatment results in a magnetic resonance spectroscopy-detectable elevation in choline-containing metabolites associated with increased expression of choline transporter SLC44A1 and phospholipase A2The potential of positron-emission tomography to study anticancer-drug resistance.The role of functional and molecular imaging in cancer drug discovery and development.MR evaluation of response to targeted treatment in cancer cells.Choline transporter-like proteins CTLs/SLC44 family as a novel molecular target for cancer therapy.Multimodal imaging of tumor response to sorafenib combined with radiation therapy: comparison between diffusion-weighted MRI, choline spectroscopy and 18F-FLT PET imaging.Transport and metabolism of radiolabeled choline in hepatocellular carcinoma.Proton MRS detects metabolic changes in hormone sensitive and resistant human prostate cancer models CWR22 and CWR22r.Phosphatidylcholine metabolic transformation and progression signature as a pharmacodynamic biomarker.Molecular and Functional Characterization of Choline Transporter-Like Proteins in Esophageal Cancer Cells and Potential Therapeutic Targets.
P2860
Q28254233-0A18AC89-853A-41A1-A24E-65552911920DQ34249948-40E0F83F-21FB-43EF-BAEE-CEB3FB4C8E21Q34989144-93F8EC50-9A1E-4417-88E1-CBCD9174F8FBQ35788120-604BE83A-213A-4B62-A076-25C4365FBF06Q35968111-D09A159F-E796-4FE1-9B9B-5A8F1485BE17Q37851076-9E25AE47-054E-4A5F-96BD-CBAD38C42875Q38188522-1C604413-1B1A-4EF5-BDCC-FA0D546B2DD6Q39162638-53AE68CA-0D13-4F3F-882F-E5BD5F8B2109Q39669104-4C879DFC-2468-43BB-BC21-588E0B960472Q39795389-B6B10F99-C0E4-401B-A3F9-FB5B19E6C674Q41813264-7D9531B3-50A6-4A47-8E10-F5E95F9ACBC1Q47312692-DA24BA48-E913-4DA5-84E4-56589D458591
P2860
Use of radiolabelled choline as a pharmacodynamic marker for the signal transduction inhibitor geldanamycin.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Use of radiolabelled choline a ...... uction inhibitor geldanamycin.
@ast
Use of radiolabelled choline a ...... uction inhibitor geldanamycin.
@en
type
label
Use of radiolabelled choline a ...... uction inhibitor geldanamycin.
@ast
Use of radiolabelled choline a ...... uction inhibitor geldanamycin.
@en
prefLabel
Use of radiolabelled choline a ...... uction inhibitor geldanamycin.
@ast
Use of radiolabelled choline a ...... uction inhibitor geldanamycin.
@en
P2093
P2860
P356
P1476
Use of radiolabelled choline a ...... uction inhibitor geldanamycin.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6600558
P407
P577
2002-09-01T00:00:00Z